NVLS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash and cash equivalents divide by its debt. Nivalis Therapeutics Inc's cash to debt ratio for the quarter that ended in Mar. 2015 was N/A.
This is the ratio of a company's Cash and cash equivalents to its debt. The debt includes the Current Portion of Long-Term Debt and Long-Term Debt. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Nivalis Therapeutics Inc's Cash to Debt Ratio for the fiscal year that ended in Dec. 2014 is calculated as:
Nivalis Therapeutics Inc had no debt.
Nivalis Therapeutics Inc's Cash to Debt Ratio for the quarter that ended in Mar. 2015 is calculated as:
Do not have enough data to calculate Cash to Debt ratio.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Nivalis Therapeutics Inc Annual Data
Nivalis Therapeutics Inc Semi-Annual Data